Sanofi (France)
NEWS
As Sanofi grapples with the fallout from its Dengue vaccine, the termination of its late-stage C. diff vaccine and falling short of its third quarter expectations, company investors are getting antsy for some good news.
It’s no secret that the life sciences are increasingly international.
There are hundreds, even thousands of biotech and pharmaceutical companies.
Sanofi said the analysis showed more cases of severe disease could occur following vaccination in patients who had not been previously infected by the dengue virus.
Sanofi terminated an experimental Clostridium difficile vaccine after an Independent Data Monitoring Committee concluded the Phase III trial was unlikely to hit its endpoints.
Sanofi’s setback could open the door for rival drugmaker Takeda.
Sanofi will write a check for $40 million upfront.
Salaries and total compensation can range from $300,000 to $500,000 per year for these employees – whether they have a Ph.D. or are just out of college.
Here are some tips for getting in the door at one of the top international pharmas in the world.
JOBS
IN THE PRESS